E88.10 Billable / specific Lipodystrophy, unspecified
ICD-10-CM E88.10 identifies “Lipodystrophy, unspecified” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
Inclusion terms1
Lipodystrophy NOS
Inherited instructions
E88 · Other and unspecified metabolic disorders
Excludes 11
histiocytosis X (chronic) (C96.6)
Use additional code1
codes for associated conditions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E70-E88 · Metabolic disorders (E70-E88)
Excludes 15
Excludes 21
Ehlers-Danlos syndromes (Q79.6-)
E88.1 · Lipodystrophy, not elsewhere classified
Excludes 11
Whipple's disease (K90.81)
Official index references
Official index references (1)
Lipodystrophy (1)
- LipodystrophyDisease index
Official conversion history
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Previous assignment: E88.1
History
Code history
Latest recorded change · FY2026
Effective from
- Added
Lipodystrophy, unspecified
Billable diagnosis code
CDC/NCHS · FY2026All editions (3)
| All editions | Effective from | Code history |
|---|---|---|
| FY2026 | 2025-10-01 | Added |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.